2296. Hypoglycemia Risk with Antibiotics: An Epidemiologic Surveillance Study of the FDA Adverse Event Reporting System (FAERS)

BACKGROUND: In July of 2018, the FDA published a drug safety warning for the potential risk of developing hypoglycemia with fluoroquinolones. Some studies have evaluated the potential risk of developing hypoglycemia with linezolid and tigecycline. A few case reports have also been published that rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Kennedy, Kaitlin E, Teng, Chengwen, Patek, Taylor M, Frei, Christopher R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810065/
http://dx.doi.org/10.1093/ofid/ofz360.1974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810065/
http://dx.doi.org/10.1093/ofid/ofz360.1974

Ejemplares similares